, for a discussion of: Operations Principal Products Distribution and Customers Competition Regulatory Matters Research and Development Strategic Imperatives for 2026 We believe we have a significant opportunity to fundamentally transform how myopia and other refractive conditions are treated. We want to be the first choice for doctors and for patients seeking visual freedom from wearing eyeglasses or contact lenses. The Company is navigating market headwinds, geopolitical factors and a dynamic ...
Q2 FY2026 — expected 2026-09-11
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-03 | 2026-01-02 | 0000718937-26-000004 | EDGAR | 70K words |
| 2025-02-21 | 2024-12-27 | 0000950170-25-024813 | EDGAR | — |
| 2024-02-27 | 2023-12-29 | 0000950170-24-020572 | EDGAR | — |
| 2023-02-23 | 2022-12-30 | 0001564590-23-002249 | EDGAR | — |
| 2022-02-23 | 2021-12-31 | 0001564590-22-006264 | EDGAR | — |
| 2021-02-24 | 2021-01-01 | 0001564590-21-008098 | EDGAR | — |
| 2020-02-26 | 2020-01-03 | 0001564590-20-006791 | EDGAR | — |
| 2019-02-21 | 2018-12-28 | 0001564590-19-003674 | EDGAR | — |
| 2018-02-28 | 2017-12-29 | 0001144204-18-011838 | EDGAR | — |
| 2017-03-02 | 2016-12-30 | 0001144204-17-012557 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-05 | 2025-09-26 | 0001193125-25-266879 | EDGAR | 25K words |
| 2025-08-06 | 2025-06-27 | 0000950170-25-103982 | EDGAR | — |
| 2025-05-07 | 2025-03-28 | 0000950170-25-065665 | EDGAR | — |
| 2024-10-30 | 2024-09-27 | 0000950170-24-118973 | EDGAR | — |
| 2024-08-07 | 2024-06-28 | 0000950170-24-092753 | EDGAR | — |
| 2024-05-07 | 2024-03-29 | 0000950170-24-054488 | EDGAR | — |
| 2023-11-06 | 2023-09-29 | 0000950170-23-058994 | EDGAR | — |
| 2023-08-02 | 2023-06-30 | 0000950170-23-037163 | EDGAR | — |
| 2023-05-03 | 2023-03-31 | 0000950170-23-017183 | EDGAR | — |
| 2022-11-02 | 2022-09-30 | 0001564590-22-036363 | EDGAR | — |
| 2022-08-10 | 2022-07-01 | 0001564590-22-028946 | EDGAR | — |
| 2022-05-04 | 2022-04-01 | 0001564590-22-017859 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-03-03 | 0000718937-26-000005 | EDGAR | 12K words |
| 2026-02-05 | 0001193125-26-038534 | EDGAR | — |
| 2026-02-02 | 0001193125-26-032630 | EDGAR | — |
| 2026-01-16 | 0001193125-26-014681 | EDGAR | — |
| 2026-01-15 | 0001193125-26-013622 | EDGAR | — |
| 2026-01-06 | 0001193125-26-004699 | EDGAR | — |
| 2026-01-06 | 0001193125-26-003534 | EDGAR | — |
| 2025-12-09 | 0001193125-25-311982 | EDGAR | — |
| 2025-12-08 | 0001193125-25-310631 | EDGAR | — |
| 2025-11-07 | 0001193125-25-271708 | EDGAR | — |
316 total filings indexed. 284 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0000718937 |
| Ticker | STAA |
| Exchange | Nasdaq |
| SIC | 3851: Ophthalmic Goods |
| Incorporated | DE |
| Website | https://www.staar.com |
| Listed | 1983-07-07 |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report